World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
35709
World Ranking
11196
National Ranking
150

Overview

Walter Weder is affiliated with the University of Zurich in Switzerland and focuses primarily on research within the field of medicine. Their work spans several subfields including pulmonary and respiratory medicine, oncology, surgery, radiology, nuclear medicine and imaging, as well as neurology. This multidisciplinary approach informs their studies on lung cancer, pleural and pulmonary diseases, and related respiratory conditions.

The scientist's main topics of investigation include:

  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Pleural and Pulmonary Diseases
  • Lung Cancer Research Studies
  • Occupational and Environmental Lung Diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Tracheal and Airway Disorders

Recent significant publications authored or co-authored by Walter Weder include:

  • IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy, 2020, Journal of Thoracic Oncology
  • Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer, 2021, Nature Reviews Clinical Oncology
  • SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial, 2021, Journal of Clinical Oncology
  • ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma, 2020, European Respiratory Journal
  • Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for EGFR-Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA, 2021, Future Oncology

Their frequent collaborators include:

  • Isabelle Opitz
  • İlhan İnci
  • Jamie E. Chaft
  • Laurens J. Ceulemans
  • Thomas Frauenfelder

Walter Weder's work has appeared extensively in specialized publication venues related to cardio-thoracic surgery and oncology:

  • European Journal of Cardio-Thoracic Surgery
  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Lung Cancer
  • European Respiratory Journal

Their research contributes to understanding and advancing treatment options for lung cancer and other respiratory diseases, integrating clinical and surgical perspectives with oncology and imaging techniques. The volume of publications and recurring topics reflect a focus on both systemic therapies and surgical interventions for thoracic diseases.

Best Publications

  • Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

    Didier Lardinois;Walter Weder;Thomas F Hany;Ehab M Kamel

  • Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George

  • Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.

    Paul De Leyn;Christophe Dooms;Jaroslaw Kuzdzal;Didier Lardinois

  • ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer

    Didier Lardinois;Paul De Leyn;Paul Van Schil;Ramon Rami Porta

  • Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

    A Scherpereel;P Astoul;P Baas;T Berghmans

  • A genomics-based classification of human lung tumors

    Danila Seidel;Thomas Zander;Lukas C. Heukamp;Martin Peifer

  • ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer

    Paul De Leyn;Didier Lardinois;Paul E. Van Schil;Ramon Rami-Porta

  • Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

    Daniel C. Betticher;Shu Fang Hsu Schmitz;Martin Tötsch;Eva Hansen

  • Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    L. Crinò;W. Weder;J. van Meerbeeck;E. Felip

  • 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    J. Vansteenkiste;L. Crinò;C. Dooms;J. Y. Douillard

  • Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.

    H C Steinert;M Hauser;F Allemann;H Engel

  • 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    W.E.E. Eberhardt;D. De Ruysscher;W. Weder;C. Le Péchoux

  • Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P. Baas;D. Fennell;K. M. Kerr;P. E. Van Schil

  • Initial analysis of the international association for the study of lung cancer mesothelioma database.

    Valerie W. Rusch;Dorothy Giroux;Catherine Kennedy;Enrico Ruffini

  • Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma

    W Weder;R A Stahel;J Bernhard;S Bodis

  • Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

    Miklos Pless;Roger Stupp;Roger Stupp;Hans Beat Ris;Rolf A. Stahel

  • Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

    Keith M. Kerr;Lukas Bubendorf;Martin J. Edelman;Antonio Marchetti

  • Anesthetic-induced improvement of the inflammatory response to one-lung ventilation.

    Elisena De Conno;Marc P. Steurer;Moritz Wittlinger;Marco P. Zalunardo

  • Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

    Oliver Gautschi;Colette Bigosch;Barbara Huegli;Monika Jermann

  • EML4-ALK Fusion Lung Cancer: A Rare Acquired Event

    Sven Perner;Patrick L Wagner;Francesca Demichelis;Rohit Mehra

Frequent Co-Authors

Rolf A. Stahel
Rolf A. Stahel University of Zurich
Solange Peters
Solange Peters University Hospital of Lausanne
Holger Moch
Holger Moch University of Zurich
Burkhardt Seifert
Burkhardt Seifert University of Zurich
Lukas Bubendorf
Lukas Bubendorf University Hospital of Basel
Roger Stupp
Roger Stupp Northwestern University
Keith M. Kerr
Keith M. Kerr Aberdeen Royal Infirmary
Paul Baas
Paul Baas Antoni van Leeuwenhoek Hospital
Walter Klepetko
Walter Klepetko Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are various alternative routes into healthcare for those interested in the medical field but seeking flexibility or different career paths. Many students explore nursing, public health, and allied health degrees, which offer rewarding opportunities and may have a quicker entry into the healthcare workforce.

Some learners begin their careers by enrolling in adn programs (Associate Degree in Nursing), known for easier entry requirements and shorter completion times. Others opt for the cheapest rn to bsn program online to upgrade their credentials as registered nurses affordably while balancing work and study.

For non-nurses with a bachelor’s degree in another field, accelerated online direct entry msn programs for non-nursing majors provide a fast path into advanced nursing practice. Experienced nurses interested in research or leadership roles might consider an online phd nursing for the highest level of academic achievement.

Exploring these diverse pathways expands your possibilities within healthcare, offering flexibility, affordability, and a range of specialties to suit different interests and backgrounds.

Best Scientists Citing Walter Weder

Trending Scientists